María Jesús Jiménez‐Expósito

Author

Also Known As

M Jesús Jiménez-Expósito, Maria Jesus Jimenez-Exposito, Maria Jesús Jiménez-Exposito, Maria Jesús Jiménez-Expósito, Maria Jimenez-Exposito, María Jesús Jiménez-Expósito, María Jesús Jiménez‐Expósito

Publications

443

Citations

H-Index

Concepts

All Affiliations

Hospital Universitari Sant Joan de Reus Bristol-Myers Squibb (United States)Klinikum Klagenfurt Goethe University Frankfurt University Hospital Bonn

About

María Jesús Jiménez‐Expósito is an author at Hospital Universitari Sant Joan de Reus specializing in medicine, viral hepatitis, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	86
2	Emergency Medicine	1	1	64
3	Hepatology	1	1	22
4	Nephrology	1	1	64
5	Autoimmune Liver Disease	1	1	22

María Jesús Jiménez‐Expósito

Publications

411

Citations

H-Index

Page 1

	Year	Citations
Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort Tania M. Welzel, Jörg Petersen, Kerstin Herzer, Gut	2016	196
Infective Endocarditis in Patients on Chronic Hemodialysis Juan M. Pericàs, Jaume Llopis, María Jesús Jiménez‐Expósito, Journal of the American College of Cardiology HemodialysisMedicineKidney FailureInfective EndocarditisDialysis Therapy	2021	64
High-density lipoprotein concentrations relate to the clinical course of HIV viral load in patients undergoing antiretroviral therapy Carlos Alonso‐Villaverde, Teresa Segués, Blai Coll-Crespo, AIDS	2003	39
Cytokine‐Driven Inflammatory Response Is Associated with the Hypermetabolism of AIDS Patients with Opportunistic Infections Pilar García‐Lorda, Pilar Serrano, María Jesús Jiménez‐Expósito, Journal of Parenteral and Enteral Nutrition	2000	37
Daclatasvir plus Sofosbuvir, with or without Ribavirin, in Real-World Patients with HIV–HCV Coinfection and Advanced Liver Disease Jürgen K. Rockstroh, Patrick Ingiliz, Jörg Petersen, Antiviral Therapy	2016	30
Effect of malabsorption on nutritional status and resting energy expenditure in HIV-infected patients María Jesús Jiménez‐Expósito, Pilar García‐Lorda, Carlos Alonso‐Villaverde, AIDS	1998	23
Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver disease Kerstin Herzer, Tania M. Welzel, Ulrich Spengler, Transplant International Real-world ExperiencePost-transplant Hcv RecurrenceAntiviral DrugAutoimmune Liver DiseaseViral Hepatitis	2016	22

Page 1